Species: Schaalia lingnae (HMT-0181) Primary Body Site: Oral
Download Options
Hide Legend
Prev - Prevalence
10thp - 10th percentile
90thp - 90th percentile
ND - less than 0.001%
Body Site Legend:
| SUBP-- Subgingival Plaque |
| SUPP -- Supragingival Plaque |
| PERIO -- Periodontal |
| AKE -- Attached Keratinized Gingiva |
| BMU -- Buccal Mucosa |
| HPA -- Hard Palate |
| SAL -- Saliva |
| THR -- Throat |
| PTO -- Palatine Tonsils |
| TDO -- Tongue Dorsum |
| ANA -- Anterior Nares |
| LRC -- L_Retroauricular Crease |
| RRC -- R_Retroauricular Crease |
| LAF -- L_Antecubital Fossa |
| RAF -- R_Antecubital Fossa |
| VIN -- Vaginal Introitus |
| MVA -- Mid Vagina |
| PFO -- Posterior Fornix |
| STO -- Stool |
Prev - Prevalence
10thp - 10th percentile
90thp - 90th percentile
ND - less than 0.001%
Human Microbiome Project Mapping (Data from healthy subjects. - not published)
No Notes
| SUBP | SUPP | PERIO | AKE | BMU | HPA | SAL | THR | PTO | TDO | ANA | LRC | RRC | RAF | VIN | MVA | PFO | STO | |
| Avg (%) | 0.01 | 0.01 | 0 | 0.02 | 0.06 | 0.04 | 0.17 | 0.31 | 0.19 | 0.72 | 0.01 | 0 | 0 | 0.09 | 0 | 0 | 0.01 | 0.01 |
| n | 24 | 395 | 24 | 15 | 323 | 1 | 8 | 7 | 22 | 423 | 65 | 23 | 30 | 1 | 4 | 8 | 94 | 375 |
| 10thp | 0 | 0 | 0 | 0 | 0 | 0.04 | 0.04 | 0.06 | 0.03 | 0.08 | 0 | 0 | 0 | 0.09 | 0 | 0 | 0 | 0 |
| 90thp | 0.01 | 0.01 | 0.01 | 0.02 | 0.14 | 0.04 | 0.35 | 0.82 | 0.42 | 1.89 | 0.03 | 0 | 0 | 0.09 | 0 | 0 | 0 | 0 |
| Stdev | 0.01 | 0.02 | 0 | 0.03 | 0.13 | 0 | 0.16 | 0.35 | 0.20 | 0.85 | 0.03 | 0 | 0 | 0 | 0 | 0 | 0.05 | 0.07 |
| Prev(%) | 4.17 | 1.01 | 0 | 13.33 | 10.53 | 100.00 | 37.50 | 85.71 | 54.55 | 95.04 | 1.54 | 0 | 0 | 0 | 0 | 0 | 0 | 0.53 |
Eren V1-V3 www.pnas.org
(Data from healthy subjects.)
Notes:
reads equally close to S. lingnae [Not Validly Published], S. sp. HMT 172, and S. sp. HMT 180 were assigned one third to each taxon
reads equally close to S. lingnae [Not Validly Published], S. sp. HMT 172, and S. sp. HMT 180 were assigned one third to each taxon
| SUBP | SUPP | AKE | BMU | HPA | SAL | THR | PTO | TDO | STO | |
| Avg (%) | 0.01 | 0.01 | 0.03 | 0.19 | 0.76 | 0.51 | 0.58 | 0.54 | 1.39 | 0 |
| n | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN |
| 10thp | 0 | 0 | 0 | 0 | 0.07 | 0.01 | 0.07 | 0.07 | 0.18 | 0 |
| 90thp | 0.02 | 0.02 | 0.08 | 0.46 | 1.41 | 1.27 | 1.14 | 1.16 | 3.07 | 0 |
| Stdev | 0.03 | 0.01 | 0.09 | 0.34 | 0.94 | 0.59 | 0.55 | 0.56 | 1.50 | 0.01 |
| Prev(%) | 16.88 | 12.99 | 33.77 | 79.22 | 96.10 | 89.61 | 96.10 | 97.40 | 100.00 | 9.09 |
Eren V3-V5 www.pnas.org
(Data from healthy subjects.)
Notes:
Reads equally close to S. meyeri, S. odontolytica, S. lingnae [Not Validly Published], S. sp. HMT 172, and S. sp. HMT 180 were divided equally among taxa.
Reads equally close to S. meyeri, S. odontolytica, S. lingnae [Not Validly Published], S. sp. HMT 172, and S. sp. HMT 180 were divided equally among taxa.
| SUBP | SUPP | AKE | BMU | HPA | SAL | THR | PTO | TDO | STO | |
| Avg (%) | 0.05 | 0.02 | 0.03 | 0.10 | 0.43 | 0.27 | 0.55 | 0.46 | 0.81 | 0 |
| n | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN |
| 10thp | 0 | 0 | 0 | 0 | 0.10 | 0.05 | 0.10 | 0.05 | 0.13 | 0 |
| 90thp | 0.08 | 0.06 | 0.08 | 0.29 | 1.00 | 0.64 | 1.18 | 1.04 | 2.05 | 0 |
| Stdev | 0.17 | 0.04 | 0.07 | 0.14 | 0.36 | 0.30 | 0.48 | 0.49 | 0.74 | 0 |
| Prev(%) | 70.95 | 69.59 | 39.87 | 89.19 | 99.32 | 100.00 | 97.97 | 97.97 | 99.32 | 5.59 |
Human Microbiome Project 16S RefSeq (V1-V3) (Data from healthy subjects. - not published)
No Notes
| SUBP | SUPP | AKE | BMU | HPA | SAL | THR | PTO | TDO | ANA | LRC | RRC | LAF | RAF | VIN | MVA | PFO | STO | |
| Avg (%) | 0 | 0 | 0 | 0 | 0.33 | 0.22 | 0.37 | 0.28 | 0.67 | 0 | 0 | 0 | 0 | 0.05 | 0 | 0 | 0 | 0 |
| n | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN |
| 10thp | 0 | 0 | 0 | 0 | 0 | 0 | 0.02 | 0.02 | 0.13 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 90thp | 0 | 0 | 0 | 0 | 0.73 | 0.56 | 0.81 | 0.56 | 1.36 | 0 | 0 | 0 | 0 | 0.04 | 0 | 0 | 0 | 0 |
| Stdev | 0 | 0 | 0 | 0 | 0.42 | 0.34 | 0.43 | 0.35 | 0.62 | 0 | 0 | 0 | 0 | 0.23 | 0 | 0 | 0 | 0 |
| Prev(%) | 0 | 0 | 0 | 0 | 85.91 | 76.15 | 91.07 | 91.33 | 98.71 | 0 | 0 | 0 | 0 | 16.59 | 0 | 0 | 0 | 0 |
Human Microbiome Project 16S RefSeq (V3-V5) (Data from healthy subjects. - not published)
No Notes
| SUBP | SUPP | AKE | BMU | HPA | SAL | THR | PTO | TDO | ANA | LRC | RRC | LAF | RAF | VIN | MVA | PFO | STO | |
| Avg (%) | 0 | 0 | 0 | 0.08 | 0.57 | 0.20 | 0.42 | 0.28 | 0.75 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| n | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN |
| 10thp | 0 | 0 | 0 | 0 | 0.02 | 0 | 0 | 0.01 | 0.09 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 90thp | 0 | 0 | 0 | 0.25 | 1.30 | 0.43 | 1.04 | 0.68 | 1.75 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Stdev | 0 | 0 | 0 | 0.14 | 0.72 | 0.25 | 0.48 | 0.35 | 0.90 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Prev(%) | 0 | 0 | 0 | 50.37 | 91.05 | 86.01 | 88.78 | 91.00 | 97.08 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Dewhirst 35x9 (35 Taxa by 9 Oral Sites. - not published)
No Notes
| SUBP | SUPP | AKE | BMU | HPA | SAL | THR | PTO | TDO | ANA | |
| Avg (%) | 0 | 0.01 | 0.08 | 0.03 | 0.12 | 0.51 | 0.22 | 0.29 | 0.52 | 0 |
| n | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN |
| 10thp | 0 | 0 | 0 | 0 | 0.01 | 0.03 | 0.03 | 0.01 | 0 | 0 |
| 90thp | 0.01 | 0.01 | 0.21 | 0.07 | 0.26 | 1.02 | 0.45 | 0.49 | 1.22 | 0 |
| Stdev | 0.01 | 0.02 | 0.20 | 0.03 | 0.11 | 0.63 | 0.20 | 0.52 | 0.92 | 0 |
| Prev(%) | 24.32 | 32.35 | 62.79 | 88.57 | 92.86 | 98.00 | 96.97 | 96.77 | 90.00 | 0 |
Human Microbiome Project Metaphlan (Data from healthy subjects. - not published)
No Notes

